Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial
Fabio Araimo(Sapienza University of Rome), Francesco Pugliese(Sapienza University of Rome), Franco Ruberto(Sapienza University of Rome), Letizia Santinelli(Sapienza University of Rome), Carmela Imperiale(Sapienza University of Rome), Francesco Alessandri(Sapienza University of Rome), Claudio Maria Mastroianni(Sapienza University of Rome), Giuseppe Pietro Innocenti(Sapienza University of Rome), Serena Zancla(Sapienza University of Rome), Gabriella d’Ettorre(Policlinico Umberto I), Gregorio Egidio Recchia(Sapienza University of Rome), Giancarlo Ceccarelli(International Organization for Migration), Federico Bilotta, Claudia Pinacchio(Sapienza University of Rome), Cristian Borrazzo(Sapienza University of Rome), A Calò(Sapienza University of Rome), Paolo Tordiglione(Sapienza University of Rome), Roberto Poscia(Policlinico Umberto I), Vera Mauro(Sapienza University of Rome)
Cited by 34
Related Papers
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264